Latest News

Alzheimer's prevention trial to monitor reactions to higher disease risk status

A new clinical trial will soon begin testing whether early medical intervention in people at risk for Alzheimer's can slow down progression of disease pathology before symptoms emerge. As part of the overall prevention trial, neurodegenerative ethics experts will monitor how learning about their risk of developing Alzheimer's impacts trial participants.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Fear, safety and the role of sleep in human PTSD: Fragmented REM sleep may hinder effective treatment

  • Study reveals drivers of Western consumers' readiness to eat insects

  • Computer games give a boost to English

  • How nerve cells communicate with each other over long distances: Travelling by resonance

  • Serotonin deficiency? Study throws into question long-held belief about depression

  • Marijuana compound may offer treatment for Alzheimer's disease, study suggests

  • Gang life brings deep health risks for girls

  • First study of brain activation in multiple sclerosis using fNIRS

  • Readers with dyslexia have disrupted network connections in the brain, map the circuitry of dyslexia shows

  • Avatars make the Internet sign to deaf people

  •